Peng Hu
No. 218 Ji Xi Road
Hefei, 230022, China
Hefei, 230022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
The changes of coagulation profiles in Kawasaki disease and its associations with clinical classification, intravenous immunoglobulin responsiveness and coronary artery involvement.
Journal: Clinical and experimental medicine
Published: May 13, 2024
Systemic glucocorticoids link to long-term microvascular injury in COVID-19.
Journal: Angiogenesis
Published: March 15, 2024
Interpreting with caution of the higher occurrence of pediatric new-onset type 1 diabetes during the COVID-19 pandemic.
Journal: Diabetes research and clinical practice
Published: November 21, 2023
More on SARS-CoV-2 Variants and Pediatric Multisystem Inflammatory Syndrome.
Journal: The New England journal of medicine
Published: July 19, 2023
The protective effects of pediatric vaccination on multisystem inflammatory syndrome in children stratified by vaccine status, types and virus variants.
Journal: International immunopharmacology
Published: July 01, 2023
COVID-19 vaccination in patients with immune-mediated inflammatory diseases receiving rituximab: A personalized regimen should be formulated.
Journal: Journal of the American Academy of Dermatology
Published: January 03, 2022
A predictive system for Henoch-Schönlein purpura nephritis established by multivariate analysis plus nomogram model in Chinese hospitalized children: A retrospective cohort study.
Journal: Journal of the American Academy of Dermatology
Published: August 06, 2021
A new scoring system for coronary artery abnormalities in Kawasaki disease.
Journal: Pediatric research
Published: April 12, 2021
Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness.
Journal: Clinical and experimental medicine
Published: January 25, 2021
Streptococcal infection in childhood Henoch-Schönlein purpura: a 5-year retrospective study from a single tertiary medical center in China, 2015-2019.
Journal: Pediatric rheumatology online journal
Published: November 10, 2020
The downstream RAF-1 signaling of fibroblast growth factor-23 participates in the osteogenetic effect caused by C-type natriuretic peptide in vitro.
Journal: Advances in medical sciences
Published: July 17, 2020
C-type natriuretic peptide stimulates osteoblastic proliferation and collagen-X expression but suppresses fibroblast growth factor-23 expression in vitro.
Journal: Pediatric rheumatology online journal
Published: December 17, 2019
Last Updated: 09/26/2026